1-10 of 10
Christine Voigt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD + AML or ALL or Poor/Very Poor Risk MDS

Sawa Ito, Christine Voigt, Constantinos Panousis, Tim Mayall, Mark Shlomchik, Jennifer Roy, Egidio Brocca Cofano, Stephanie Stras, David Apelian, Warren D Shlomchik
Journal: Blood
Blood (2022) 140 (Supplement 1): 7482–7483.
https://doi.org/10.1182/blood-2022-168949
Published: 2022
Journal Articles

Profiling T Cell Receptor Repertoires in Phase I/II Clinical Trials of Donor Treg Infusion for the Treatment of Chronic Graft-Versus-Host Disease

Hans-Jörg Warnatz, PhD, Rita I Azevedo, PhD, Maria G.D Soares, PhD, Ana C Alho, MD, Laura C Ward, PhD, Ana C Ribeiro, MSc, Clara Juncal, MD, Anabela Rodrigues, MD, Ana Garção, MD, Susana Roncon, MD, Carlos Pinho Vaz, MD, Christine Voigt, PhD, Marie-Laure Yaspo, PhD, Hans Lehrach, PhD, Matthias Edinger, MD PhD, Frédéric Baron, MD PhD, Mario Arpinati, MD PhD, Marta Garcia-Fiñana, PhD, Jerome Ritz, MD PhD, João F Lacerda, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4563.
https://doi.org/10.1182/blood-2018-99-111866
Published: 2018
Journal Articles

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

Clinical Trials & Observations
Elena Santagostino, Uri Martinowitz, Toshko Lissitchkov, Brigitte Pan-Petesch, Hideji Hanabusa, Johannes Oldenburg, Lisa Boggio, Claude Negrier, Ingrid Pabinger, Mario von Depka Prondzinski, Carmen Altisent, Giancarlo Castaman, Koji Yamamoto, Maria-Teresa Álvarez-Roman, Christine Voigt, Nicole Blackman, Iris Jacobs
Journal: Blood
Blood (2016) 127 (14): 1761–1769.
https://doi.org/10.1182/blood-2015-09-669234
Published: 2016
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B Undergoing Major Orthopedic Surgeries

Claude Negrier, MD, Lynda Mae Lepatan, MD, Faralzah Karim, MD, Anne Lienhart, MD, Denise Wolko, Christine Voigt, PhD, Iris C. Jacobs, MD, Elena Santagostino, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2298.
https://doi.org/10.1182/blood.V126.23.2298.2298
Published: 2015
Journal Articles

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program

Aaron Lubetsky, MD, Uri Martinowitz, MD, Toshko Lissitchkov, MD, Christine Voigt, PhD, Denise Wolko, Iris C. Jacobs, MD, Elena Santagostino, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1096.
https://doi.org/10.1182/blood.V126.23.1096.1096
Published: 2015
Journal Articles

Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B

Elena Santagostino, MD PhD, Christine Voigt, PhD, Denise Wolko, Grace Cole, Yanyan Li, PhD, Iris C. Jacobs, MD
Journal: Blood
Blood (2015) 126 (23): 548.
https://doi.org/10.1182/blood.V126.23.548.548
Published: 2015
Journal Articles

Pharmacokinetic Results of Two Phase III Clinical Studies of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B (PROLONG-9FP)

Elena Santagostino, MD PhD, Iris C. Jacobs, MD, Christine Voigt, PhD, Annettee Feussner, PhD, Tharin Limsakun, PhD
Journal: Blood
Blood (2014) 124 (21): 1491.
https://doi.org/10.1182/blood.V124.21.1491.1491
Published: 2014
Journal Articles

Efficacy, PK and Safety Results of Clinical Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) In Previously Treated Patients With Hemophilia B

Aaron Lubetsky, MD MSc, Toshko Lissitchkov, MD, Elena Santagostino, MD, PhD, Gantcho Jotov, MD, Tami Barazani-Brutman, Ph.D, Christine Voigt, Ph.D, Tina Moises, Ph.D, Iris C. Jacobs, MD, Uri Martinowitz, MD
Journal: Blood
Blood (2013) 122 (21): 1109.
https://doi.org/10.1182/blood.V122.21.1109.1109
Published: 2013
Journal Articles

Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Haemophilia B (PROLONG - 9FP)

Uriel Martinowitz, MD, Aaron Lubetsky, MD, Elena Santagostino, MD, PhD, Gantcho Jotov, MD, Jacob Luboshitz, MD, Shadan Lalezari, MD, Tami Barazani-Brutman, Ph.D, Christine Voigt, Ph.D, Tina Moises, Ph.D, Iris C. Jacobs, MD, Toshko Lissitchkov
Journal: Blood
Blood (2012) 120 (21): 1121.
https://doi.org/10.1182/blood.V120.21.1121.1121
Published: 2012
Journal Articles

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

Clinical Trials & Observations
Elena Santagostino, Claude Negrier, Robert Klamroth, Andreas Tiede, Ingrid Pabinger-Fasching, Christine Voigt, Iris Jacobs, Massimo Morfini
Journal: Blood
Blood (2012) 120 (12): 2405–2411.
https://doi.org/10.1182/blood-2012-05-429688
Published: 2012